Literature DB >> 10446866

Tumor necrosis factor receptor p55 controls the severity of arthritis in experimental Yersinia enterocolitica infection.

Y X Zhao1, H Zhang, B Chiu, U Payne, R D Inman.   

Abstract

OBJECTIVE: To dissect the host defense mechanisms in relation to the development of Yersinia-associated arthritis by evaluating the impact of tumor necrosis factor receptor p55 (TNFRp55) deficiency on Yersinia enterocolitica infection.
METHODS: TNFRp55-/- and C57BL/6 mice were inoculated intravenously with arthritogenic strain 8081 of Yenterocolitica serotype 0:8. Mice were observed daily for generating survival curves and monitoring arthritis. In subsequent sets of experiments, mice were sacrificed at day 14 after infection for examination of histopathology of joints, bacterial clearance, macrophage microbicidal activity, nitric oxide (NO) production, oxidative burst generation, and cytokine production.
RESULTS: There was an 80% mortality rate in TNFRp55-/- mice compared with 25% in the controls at 8 weeks after inoculation with 70 colony-forming units of Y. enterocolitica 0:8. Histologic examination of joint tissues revealed that TNFRp55-/- mice developed more severe arthritis, including cartilage degradation and bony destruction, than controls at day 14 after infection. The more extensive joint pathology in TNFRp55-/- mice was correlated with the higher bacterial load in liver, spleen, and lungs, and with the increased levels of interleukin-10. TNFRp55-/- mice displayed impaired intracellular killing of bacteria by macrophages. This was associated with decreased NO production and impaired oxidative burst activity.
CONCLUSION: This study demonstrates that TNF signaling through TNFRp55 controls the severity of Yersinia-induced arthritis and implicates TNF-mediated macrophage microbicidal activity as a central event in this process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446866     DOI: 10.1002/1529-0131(199908)42:8<1662::AID-ANR15>3.0.CO;2-8

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  5 in total

Review 1.  Recent developments in the therapy of spondyloarthropathies.

Authors:  M Stone; R D Inman
Journal:  Curr Rheumatol Rep       Date:  2000-08       Impact factor: 4.592

2.  Tumor necrosis factor receptor p55-deficient mice respond to acute Yersinia enterocolitica infection with less apoptosis and more effective host resistance.

Authors:  Y X Zhao; G Lajoie; H Zhang; B Chiu; U Payne; R D Inman
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

3.  Altered host:pathogen interactions conferred by the Blau syndrome mutation of NOD2.

Authors:  Tae-Hwan Kim; Ursula Payne; Xiang Zhang; Yoichi Iwanaga; Michael P Davey; James T Rosenbaum; Robert D Inman
Journal:  Rheumatol Int       Date:  2006-11-10       Impact factor: 2.631

4.  Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent.

Authors:  J Adriaansen; M Khoury; C J de Cortie; F J Fallaux; P Bigey; D Scherman; D J Gould; Y Chernajovsky; F Apparailly; C Jorgensen; M J B M Vervoordeldonk; P P Tak
Journal:  Ann Rheum Dis       Date:  2007-03-15       Impact factor: 19.103

Review 5.  The role of intracellular organisms in the pathogenesis of inflammatory arthritis.

Authors:  Animesh Singh; Sarah Karrar
Journal:  Int J Inflam       Date:  2014-06-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.